Financhill
Sell
1

NLCP Quote, Financials, Valuation and Earnings

Last price:
$13.05
Seasonality move :
-3.23%
Day range:
$12.50 - $14.40
52-week range:
$12.50 - $21.46
Dividend yield:
13.18%
P/E ratio:
10.36x
P/S ratio:
5.46x
P/B ratio:
0.68x
Volume:
139.5K
Avg. volume:
45.7K
1-year change:
-30.84%
Market cap:
$268M
Revenue:
$50.1M
EPS (TTM):
$1.26

Analysts' Opinion

  • Consensus Rating
    NewLake Capital Partners has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $20.00, NewLake Capital Partners has an estimated upside of 53.26% from its current price of $13.05.
  • Price Target Downside
    According to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $13.05.

Fair Value

  • According to the consensus of 1 analyst, NewLake Capital Partners has 53.26% upside to fair value with a price target of $20.00 per share.

NLCP vs. S&P 500

  • Over the past 5 trading days, NewLake Capital Partners has underperformed the S&P 500 by -2.42% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • NewLake Capital Partners does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • NewLake Capital Partners revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter NewLake Capital Partners reported revenues of $12.5M.

Earnings Growth

  • NewLake Capital Partners earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter NewLake Capital Partners reported earnings per share of $0.29.
Enterprise value:
262.6M
EV / Invested capital:
--
Price / LTM sales:
5.46x
EV / EBIT:
9.67x
EV / Revenue:
5.24x
PEG ratio (5yr expected):
1.08x
EV / Free cash flow:
6.06x
Price / Operating cash flow:
6.31x
Enterprise value / EBITDA:
6.27x
Gross Profit (TTM):
$49.9M
Return On Assets:
6.02%
Net Income Margin (TTM):
52.1%
Return On Equity:
6.39%
Return On Invested Capital:
6.3%
Operating Margin:
53.86%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $45M $47.3M $50.1M $13M $12.5M
Gross Profit -- $46.6M $49.9M $12.6M $12.5M
Operating Income $22.6M $24.7M $27.3M $7M $6.7M
EBITDA $35.5M $39.7M $41.9M $10.8M $10.1M
Diluted EPS $1.02 $1.15 $1.26 $0.33 $0.29
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $20.2M $157.1M $50.2M $30.7M $25.1M
Total Assets $144.2M $460.9M $454.2M $433.3M $431.5M
Current Liabilities $3.1M $15.6M $20.3M $20.1M $27.2M
Total Liabilities $3.1M $21.5M $23.3M $21.3M $27.6M
Total Equity $141M $439.3M $430.9M $412M $404M
Total Debt -- $3.8M $3M $2M $7.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $37M $40.1M $43.3M $12.5M $10.6M
Cash From Investing -$86.5M -$12.8M -$19.1M -$6.9M -$1.2M
Cash From Financing -$32.5M -$46.6M -$29.8M -$10.8M -$9.1M
Free Cash Flow $37M $40.1M $43.3M $12.5M $10.6M
NLCP
Sector
Market Cap
$268M
$1B
Price % of 52-Week High
60.81%
78.55%
Dividend Yield
13.18%
3.44%
Shareholder Yield
9.4%
3.41%
1-Year Price Total Return
-30.84%
-3.56%
Beta (5-Year)
--
0.770
Dividend yield:
13.18%
Annualized payout:
$1.70
Payout ratio:
131.81%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $14.48
200-day SMA
Sell
Level $18.31
Bollinger Bands (100)
Sell
Level 15.37 - 18.41
Chaikin Money Flow
Sell
Level -2.5M
20-day SMA
Sell
Level $14.94
Relative Strength Index (RSI14)
Sell
Level 16.63
ADX Line
Sell
Level 38.7
Williams %R
Neutral
Level -80
50-day SMA
Sell
Level $15.69
MACD (12, 26)
Sell
Level -0.50
25-day Aroon Oscillator
Sell
Level -84
On Balance Volume
Sell
Level -3.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (7.9703)
Buy
CA Score (Annual)
Level (1.8214)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-4.4488)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

NewLake Capital Partners Inc is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions, third-party purchases, and funding for build-to-suit projects. The company own a geographically diversified portfolio consisting of thirty one properties across twelve states with thirteen tenants, comprised of seventeen dispensaries and fourteen cultivation facilities.

Stock Forecast FAQ

In the current month, NLCP has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NLCP average analyst price target in the past 3 months is $20.00.

  • Where Will NewLake Capital Partners Stock Be In 1 Year?

    According to analysts, the consensus estimate is that NewLake Capital Partners share price will rise to $20.00 per share over the next 12 months.

  • What Do Analysts Say About NewLake Capital Partners?

    Analysts are divided on their view about NewLake Capital Partners share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NewLake Capital Partners is a Sell and believe this share price will drop from its current level to $20.00.

  • What Is NewLake Capital Partners's Price Target?

    The price target for NewLake Capital Partners over the next 1-year time period is forecast to be $20.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is NLCP A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for NewLake Capital Partners is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of NLCP?

    You can purchase shares of NewLake Capital Partners via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NewLake Capital Partners shares.

  • What Is The NewLake Capital Partners Share Price Today?

    NewLake Capital Partners was last trading at $13.05 per share. This represents the most recent stock quote for NewLake Capital Partners. Yesterday, NewLake Capital Partners closed at $13.05 per share.

  • How To Buy NewLake Capital Partners Stock Online?

    In order to purchase NewLake Capital Partners stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Is Fidelity High Dividend ETF a Good Investment Now?
Is Fidelity High Dividend ETF a Good Investment Now?

Fidelity’s High Dividend ETF (FDVV) is a fund that offers…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock